• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见卵巢肿瘤的生育力保存。

Fertility preservation in rare ovarian tumors.

机构信息

Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

Int J Gynecol Cancer. 2021 Mar;31(3):432-441. doi: 10.1136/ijgc-2020-001775.

DOI:10.1136/ijgc-2020-001775
PMID:33649010
Abstract

Although gynecologic cancers usually affect older women, a significant proportion of patients with rare ovarian tumors are of reproductive age. In a young patient who presents with a pelvic mass, a primary consideration should be the probability of a malignancy. If there is any suspicion of a cancer diagnosis, the patient should be referred to a gynecologic oncologist. Key factors in clinical management include assessment of preoperative studies (physical examination, tumor markers, and imaging) to determine the likelihood of a malignancy, appropriate preoperative counseling (including discussion of fertility preservation), choice of surgical approach (minimally invasive vs open), frozen section examination by a gynecologic pathologist, and intraoperative decision making. Fortunately, the clinical features of several rare ovarian tumors are compatible with fertility preservation. These characteristics include a high proportion of stage I disease and unilateral ovarian involvement for most rare histotypes. Once a final diagnosis of a rare ovarian tumor is determined, further clinical management may include the need for further studies, possible referral to a fertility expert, consideration of further surgery (if the initial surgery was incomplete), and recommendations for postoperative therapy. This article reviews the literature on fertility preservation in the context of the treatment of several rare ovarian tumor subtypes, including malignant germ cell tumors, sex cord-stromal tumors, borderline tumors, low grade serous carcinoma, clear cell carcinoma, mucinous carcinoma, and small cell carcinoma of the hypercalcemic type.

摘要

尽管妇科癌症通常影响老年女性,但相当一部分罕见卵巢肿瘤患者处于生育年龄。对于出现盆腔肿块的年轻患者,首要考虑因素应该是恶性肿瘤的可能性。如果怀疑癌症诊断,应将患者转介给妇科肿瘤学家。临床管理的关键因素包括评估术前检查(体格检查、肿瘤标志物和影像学)以确定恶性肿瘤的可能性、适当的术前咨询(包括讨论生育力保存)、手术方式的选择(微创与开放)、妇科病理学家进行的冰冻切片检查以及术中决策。幸运的是,几种罕见卵巢肿瘤的临床特征与生育力保存兼容。这些特征包括大多数罕见组织学类型的Ⅰ期疾病和单侧卵巢受累的高比例。一旦确定了罕见卵巢肿瘤的最终诊断,进一步的临床管理可能包括需要进一步研究、可能转介给生育专家、考虑进一步手术(如果初始手术不完整),以及推荐术后治疗。本文综述了在治疗几种罕见卵巢肿瘤亚型(包括恶性生殖细胞肿瘤、性索-间质肿瘤、交界性肿瘤、低级别浆液性癌、透明细胞癌、黏液性癌和高钙血症型小细胞癌)时生育力保存的文献。

相似文献

1
Fertility preservation in rare ovarian tumors.罕见卵巢肿瘤的生育力保存。
Int J Gynecol Cancer. 2021 Mar;31(3):432-441. doi: 10.1136/ijgc-2020-001775.
2
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.交界性卵巢肿瘤:法国 CNGOF 指南。第 2 部分。手术管理、随访、激素替代治疗、生育管理和保存。
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101966. doi: 10.1016/j.jogoh.2020.101966. Epub 2020 Nov 2.
3
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].[交界性卵巢肿瘤:CNGOF临床实践指南——早期阶段的治疗管理]
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):287-303. doi: 10.1016/j.gofs.2020.01.016. Epub 2020 Jan 28.
4
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].[罕见卵巢肿瘤女性患者的生育力保存、避孕及绝经激素治疗:法国罕见妇科癌症国家网络指南]
Bull Cancer. 2018 Mar;105(3):299-314. doi: 10.1016/j.bulcan.2017.10.032.
5
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.临床病理和手术因素对年轻患者(≤40 岁)交界性卵巢肿瘤复发和妊娠的影响。
BMC Cancer. 2018 Nov 21;18(1):1147. doi: 10.1186/s12885-018-4932-2.
6
[Methods and conditions of fertility preservation in early-stage ovarian tumors].[早期卵巢肿瘤生育力保存的方法与条件]
Orv Hetil. 2013 Apr 7;154(14):523-30. doi: 10.1556/OH.2013.29581.
7
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).卵巢交界性肿瘤:法国国家妇产科医师学会(CNGOF)指南
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:492-501. doi: 10.1016/j.ejogrb.2020.11.045. Epub 2020 Nov 20.
8
Management of borderline ovarian tumours.卵巢交界性肿瘤的管理
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:49-59. doi: 10.1016/j.bpobgyn.2016.09.012. Epub 2016 Oct 3.
9
Advances in fertility preserving surgery for borderline ovarian tumors.交界性卵巢肿瘤保留生育功能手术的进展。
Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:206-211. doi: 10.1016/j.ejogrb.2021.11.428. Epub 2021 Nov 25.
10
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text].[卵巢交界性肿瘤:CNGOF临床实践指南 - 简短文本]
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):223-235. doi: 10.1016/j.gofs.2020.01.022. Epub 2020 Jan 28.

引用本文的文献

1
Targeted Therapies in Low-Grade Serous Ovarian Cancers.低级别浆液性卵巢癌的靶向治疗。
Curr Treat Options Oncol. 2024 Jul;25(7):854-868. doi: 10.1007/s11864-024-01205-4. Epub 2024 Jun 13.
2
Low-grade serous ovarian cancer: expert consensus report on the state of the science.低级别浆液性卵巢癌:科学现状的专家共识报告。
Int J Gynecol Cancer. 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610.
3
Granulosa tumor: two spontaneous pregnancies after combined medico-surgical treatment: case report and review of the literature.
颗粒细胞瘤:联合药物-手术治疗后两次自然妊娠:病例报告及文献复习。
J Med Case Rep. 2023 Mar 30;17(1):135. doi: 10.1186/s13256-023-03793-5.
4
The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery.I期黏液性卵巢癌患者接受保留生育功能手术后化疗的效果。
Front Oncol. 2022 Nov 8;12:1028842. doi: 10.3389/fonc.2022.1028842. eCollection 2022.
5
Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.I期黏液性卵巢癌保留生育功能手术后的肿瘤学及生殖结局
Front Oncol. 2022 Jul 4;12:856818. doi: 10.3389/fonc.2022.856818. eCollection 2022.